Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod

Figure 1

Overview. Survey of treatment decisions and laboratory and MRI findings of the patient under discussion. In detail, 1.5 T T1 weighted Gadolinium enhanced (T1W GAD) and 1.5 T fluid attenuated inversion recovery (FLAIR) images are presented.